Puck, Jennifer

A prudent path forward for genomic engineering and germline gene modification

Baltimore, D., Berg, P., Botchan, M., Carroll, D., Charo, R. A., Church, G., Corn, J. E., Daley, G. Q., Doudna, J. A., Fenner, M., et al. (2015) · Science

CRISPR and Genetic EngineeringBiomedical Ethics and Regulation

Cited by 733

Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1

Mamcarz, E., Zhou, S., Lockey, T., Abdelsamed, H., Cross, S. J., Kang, G., Ma, Z., Condori, J., Dowdy, J., Triplett, B., et al. (2019) · New England Journal of Medicine

Virus-based gene therapy researchImmunodeficiency and Autoimmune Disorders

Cited by 263

Treatment of patients with new onset type 1 diabetes with a single course of anti-CD3 mAb teplizumab preserves insulin production for up to 5 years

Herold, K. C., Gitelman, S., Greenbaum, C., Puck, J., Hagopian, W., Gottlieb, P., Sayre, P., Bianchine, P., Wong, E., Seyfert-Margolis, V., et al. (2009) · Clinical Immunology

Diabetes and associated disordersT-cell and B-cell Immunology

Cited by 219

The Ever-Increasing Array of Novel Inborn Errors of Immunity: an Interim Update by the IUIS Committee

Tangye, S. G., Al-Herz, W., Bousfiha, A., Cunningham-Rundles, C., Franco, J. L., Holland, S. M., Klein, C., Morio, T., Oksenhendler, E., Picard, C., et al. (2021) · Journal of Clinical Immunology

Immunodeficiency and Autoimmune DisordersBlood disorders and treatments

Cited by 214

An update on the hyper-IgE syndromes

Yong, P. F., Freeman, A. F., Engelhardt, K. R., Holland, S., Puck, J. M., & Grimbacher, B. (2012) · Arthritis Research & Therapy

Immunodeficiency and Autoimmune DisordersBlood disorders and treatments

Cited by 154

Constrained chromatin accessibility in PU.1-mutated agammaglobulinemia patients

Le Coz, C., Nguyen, D. N., Su, C., Nolan, B. E., Albrecht, A. V., Xhani, S., Sun, D., Demaree, B., Pillarisetti, P., Khanna, C., et al. (2021) · Journal of Experimental Medicine

Immunodeficiency and Autoimmune DisordersGenomics and Chromatin Dynamics

Cited by 69

Long-Term Tolerability, Safety, and Efficacy of Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Human Immunoglobulin for Primary Immunodeficiency

Wasserman, R. L., Melamed, I., Stein, M. R., Engl, W., Sharkhawy, M., Leibl, H., Puck, J., Rubinstein, A., Kobrynski, L., Gupta, S., et al. (2016) · Journal of Clinical Immunology

Immunodeficiency and Autoimmune DisordersMonoclonal and Polyclonal Antibodies Research

Cited by 52